Purinergic neurotransmission receptor P2X4 silencing alleviates intracerebral hemorrhage-induced neuroinflammation by blocking the NLRP1/Caspase-1 pathway

© 2023. Springer Nature Limited..

This study is performed to explore the role of P2X4 in intracerebral hemorrhage (ICH) and the association between P2X4 and the NLRP1/Caspase-1 pathway. The mouse ICH model was established via collagenase injection into the right basal ganglia. P2X4 expression in brain tissues was knocked down via intracerebroventricular injection with adeno-associated virus (AAV) harboring shRNA against shP2X4. The gene expression of P2X4 and protein levels related to NLRP1 inflammasome were detected using qRT-PCR and Western blot analysis, respectively. Muramyl dipeptide (an activator of NLRP1) was used to activate NLRP1 in brain tissues. ICH induced high expression of P2X4 in mouse brain tissues. The knockdown of P2X4 alleviated short- and long-term neurological deficits of ICH mice, as well as inhibited the tissue expression and serum levels of pro-inflammatory cytokines, including TNF-α, interleukin (IL)-6, and IL-1β. Additionally, the expressions of NLRP1, ASC, and pro-Caspase-1 were down-regulated upon P2X4 silencing. Moreover, neurological impairment and the expression and secretion of cytokines after P2X4 silencing were aggravated by the additional administration of MDP. P2X4 knockdown represses neuroinflammation in brain tissues after ICH. Mechanistically, P2X4 inhibition exerts a neuroprotective effect in ICH by blocking the NLRP1/Caspase-1 pathway.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Scientific reports - 13(2023), 1 vom: 31. Aug., Seite 14288

Sprache:

Englisch

Beteiligte Personen:

Wu, Yuanshui [VerfasserIn]
Huang, Xiaoli [VerfasserIn]
Yang, Le [VerfasserIn]
Liu, Yuanjie [VerfasserIn]

Links:

Volltext

Themen:

Caspase 1
Cytokines
EC 3.4.22.36
Interleukin-6
Journal Article
NALP1 protein, mouse
Receptors, Purinergic P2X4
Tumor Necrosis Factor-alpha

Anmerkungen:

Date Completed 02.11.2023

Date Revised 21.11.2023

published: Electronic

Citation Status MEDLINE

doi:

10.1038/s41598-023-40748-8

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM361507453